Talis Biomedical Corporation (TLIS)
USD 1.84
(3.37%)
USD 1.84
(3.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 412 Thousand | 3.65 Million | - | 10.93 Million | 3.97 Million | 2.39 Million |
| Cost of Revenue | 41 Thousand | 8.39 Million | 2.62 Million | - | - | - |
| Gross Profit | 371 Thousand | -4.73 Million | -2.62 Million | 10.93 Million | 3.97 Million | 2.39 Million |
| Operating Expenses | 67.18 Million | 110.4 Million | 191.81 Million | 91.18 Million | 26.69 Million | 21.43 Million |
| Selling, General and Administrative Expenses | 28.21 Million | 40.72 Million | 42.41 Million | 13.1 Million | 6.86 Million | 5.43 Million |
| Research and Development Expenses | 40.69 Million | 70.83 Million | 157.59 Million | 89.01 Million | 23.81 Million | 18.38 Million |
| Other Expenses | -1.72 Million | -1.16 Million | -8.19 Million | -10.93 Million | -3.97 Million | - |
| Cost and Expenses | 67.22 Million | 118.79 Million | 191.81 Million | 91.18 Million | 26.69 Million | 21.43 Million |
| Operating Income | -66.81 Million | -115.13 Million | -191.81 Million | -91.18 Million | -26.69 Million | -21.43 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -2.12 Million | -1.57 Million | -54 Thousand | -42 Thousand | 93 Thousand |
| Earnings before Tax | -62 Million | -113.01 Million | -192.03 Million | -91.13 Million | -27.47 Million | -21.33 Million |
| Net Income | -62 Million | -110.88 Million | -190.45 Million | -91.07 Million | -27.43 Million | -21.33 Million |
| Earnings Per Share Basic | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
| Earnings Per Share Diluted | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
| Weighted Average Shares Outstanding | 1.81 Million | 1.77 Million | 1.51 Million | 290 Thousand | 150 Thousand | 150.42 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.81 Million | 1.77 Million | 1.51 Million | 290 Thousand | 150 Thousand | 150.42 Thousand |
| Gross Margin | 0.90 | -1.30 | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -160.30 | -31.53 | - | -8.27 | -6.53 | -8.70 |
| Profit Margin | -150.50 | -30.36 | - | -8.33 | -6.90 | -8.93 |
| EBITDA | -66.04 Million | -106.3 Million | -191.81 Million | -90.42 Million | -25.97 Million | -20.78 Million |
| Earnings Before Tax Margin | -162.17 | -31.53 | - | -8.34 | -6.71 | -8.97 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 73 Thousand | 151 Thousand | 412 Thousand | 76 Thousand | 48 Thousand |
| Cost of Revenue | 84 Thousand | 268 Thousand | 622 Thousand | 5.11 Million | 6000.00 | 7000.00 |
| Gross Profit | -84 Thousand | -195 Thousand | -471 Thousand | -4.7 Million | 70 Thousand | 41 Thousand |
| Operating Expenses | 8.49 Million | 8.95 Million | 14.02 Million | 61.06 Million | 17.04 Million | 16.43 Million |
| Selling, General and Administrative Expenses | 6.89 Million | 6.41 Million | 5.98 Million | - | 8.8 Million | 6.41 Million |
| Research and Development Expenses | 1.6 Million | 2.53 Million | 8.04 Million | - | 8.3 Million | 10.55 Million |
| Other Expenses | 729 Thousand | 1.08 Million | 996 Thousand | 4.8 Million | 1.28 Million | 1.35 Million |
| Cost and Expenses | 8.57 Million | 9.21 Million | 14.65 Million | 66.18 Million | 17.04 Million | 16.43 Million |
| Operating Income | -8.57 Million | -9.14 Million | -14.5 Million | -65.77 Million | -16.97 Million | -16.39 Million |
| Interest Expense | - | - | 1.16 Million | - | - | - |
| Income Tax Expense | - | 218.72 Thousand | 1.16 Million | 4.9 Million | 256.58 Thousand | 45.91 Thousand |
| Earnings before Tax | -8.84 Million | -13.03 Million | -13.46 Million | -62 Million | -15.68 Million | -15.03 Million |
| Net Income | -8.84 Million | -13.03 Million | -13.46 Million | -62 Million | -15.68 Million | -15.03 Million |
| Earnings Per Share Basic | -4.86 | -7.15 | -7.40 | - | -8.62 | -8.27 |
| Earnings Per Share Diluted | -4.86 | -7.15 | -7.40 | - | -8.62 | -8.27 |
| Weighted Average Shares Outstanding | 1.82 Million | 1.82 Million | 1.82 Million | 1.81 Million | 1.81 Million | 1.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.82 Million | 1.82 Million | 1.82 Million | 1.81 Million | 1.81 Million | 1.81 Million |
| Gross Margin | - | -2.67 | -3.12 | -11.42 | 0.92 | 0.85 |
| EBIT Margin | - | -121.70 | -91.96 | - | -220.45 | -337.98 |
| Profit Margin | - | -178.56 | -89.14 | -150.50 | -206.34 | -313.21 |
| EBITDA | -8.49 Million | -8.88 Million | -13.88 Million | - | -16.75 Million | -16.22 Million |
| Earnings Before Tax Margin | - | -125.29 | -96.03 | -159.64 | -223.30 | -341.48 |
9969
0623
102940
STECF
2904
HBFG